Výsledky vyhledávání - "B van Kessel"

Identifying components for programmatic latent tuberculosis infection control in the European Union

Autor: Marieke J. van der Werf, Sake J. de Vlas, Jannigje M Vonk Noordegraaf-Schouten, Andreas Sandgren, Gerarda B van Kessel, Anouk M. Oordt-Speets

Publikováno v: Eurosurveillance, 21(34):30325, 20-24. European Centre for Disease Prevention and Control (ECDC)
Eurosurveillance

Individuals with latent tuberculosis infection (LTBI) are the reservoir of Mycobacterium tuberculosis in a population and as long as this reservoir exists, elimination of tuberculosis (TB) will not be feasible. In 2013, the European Centre for Diseas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a4e942053b4a319dafb8159e939f054
https://doi.org/10.2807/1560-7917.es.2016.21.34.30325

Zobrazit plný text záznamu

Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab

Autor: Anton C.M. Martens, K Sasser, J van Velzen, Richard W.J. Groen, Huipin Yuan, Inger S. Nijhof, N W C J van de Donk, R de Jong-Korlaar, H. M. Lokhorst, Saskia K. Klein, Parul Doshi, Andries C. Bloem, Willy A. Noort, B. van Kessel, T. Mutis

Publikováno v: Leukemia, 29(10), 2039-2049. Nature Publishing Group
Nijhof, I S, Groen, R W J, Lokhorst, H M, van Kessel, B, Bloem, A C, van Velzen, J, de Jong-Korlaar, R, Yuan, H, Noort, W A, Klein, S K, Martens, A C M, Doshi, P, Sasser, K, Mutis, T & van de Donk, N W C J 2015, ' Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab ', Leukemia, vol. 29, no. 10, pp. 2039-2049 . https://doi.org/10.1038/leu.2015.123

Daratumumab is an anti-CD38 monoclonal antibody with lytic activity against multiple myeloma (MM) cells, including ADCC (antibody-dependent cellular cytotoxicity) and CDC (complement-dependent cytotoxicity). Owing to a marked heterogeneity of respons

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35dcd8d61e20048e5b679634d5545296
https://research.vumc.nl/en/publications/ca29429e-4b4f-4b38-a519-33e9d74aec23

Zobrazit plný text záznamu

The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies

Autor: Paul W. H. I. Parren, Shulamiet Wittebol, Joost M. Bakker, H M Lokhorst, M de Weers, Tuna Mutis, M S van der Veer, B van Kessel

Publikováno v: Blood cancer journal, 1(10):e41. Nature Publishing Group
Van Der Veer, M S, De Weers, M, Van Kessel, B, Bakker, J M, Wittebol, S, Parren, P W H I, Lokhorst, H M & Mutis, T 2011, ' The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies ', Blood cancer journal, vol. 1, no. 10, e41 . https://doi.org/10.1038/bcj.2011.42
Blood Cancer Journal

Multiple myeloma (MM) is an incurable malignancy of antibody-producing clonal plasma cells. The mean life expectancy of patients has remained at

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::362c3343e92cc1c4b33187fcea0b73e7
https://research.vumc.nl/en/publications/c4aa3507-e860-4e03-b425-a07b3deb058f

Zobrazit plný text záznamu

Antigens shared by malignant plasma cells and normal B cells may be involved in graft versus myeloma

Autor: N. Kaldenhoven, H. M. Kok-Schoemaker, A. C. Bloem, B. van Kessel, H. M. Lokhorst, W. T. M. van Blokland, P. A. Holloway

Publikováno v: Clinical and experimental immunology. 131(2)

SUMMARY Cytotoxic T cells play an important role in graft-versus-host-disease (GvHD) and graft-versus-leukaemia/myeloma, which may occur in patients treated with an allogeneic stem cell transplantation (ASCT). Here, we describe the selection of a mye

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7516d19f6506f444a76a5e5df964abe5
https://pubmed.ncbi.nlm.nih.gov/12562398

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání